What adverse effects can occur in newborns exposed to zuclopenthixol decanoate during the third trimester of pregnancy?

Third-trimester exposure to zuclopenthixol decanoate may cause neonatal extrapyramidal and/or withdrawal symptoms of variable severity and duration after birth, including agitation, increased or reduced muscle tone, tremor, sleepiness, respiratory distress or feeding difficulties; newborns should be monitored carefully.